Australian Institute for Bioengineering and Nanotechnology adopts Solentim Cell Metric for rapid vaccine program
The Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland has adopted the market-leading Cell Metric® whole well imaging system from Solentim to support its Rapid Response Vaccine Pipeline. The UQ team was funded by Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership launched in 2017 to develop vaccines to stop future epidemics. Its mission is to accelerate the development of vaccines against emerging infectious diseases and enable equitable access to these vaccines during outbreaks.
Cell Metric is a high contrast imager designed for single cell imaging, identification and clonal outgrowth characterization and is being used internationally in vaccine development applications to fight the COVID-19 pandemic. Cell Metric captures a whole well image of the single cell at day 0 and records images every day from there on. This key evidence of clonal derivation forms the core of a clonality report ready for Master Cell Bank production. The instrument will be located at the National Biologics Facility housed within the AIBN at the University of Queensland.
“We’re pleased to incorporate Cell Metric into our rapid response vaccine research”, says Professor Trent Munro, Senior Group leader at the Australian Institute for Bioengineering and Nanotechnology. “The instrument’s high clarity whole well imaging will be a bedrock of our evidence of clonal origin and a solid basis for rapid vaccine development.”
More information https://www.solentim.com/products/cell-metric/